<?xml version="1.0" encoding="UTF-8"?>
<EXPERIMENT_SET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <EXPERIMENT accession="SRX23811016" alias="CA-CDPH-6000004366_01">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX23811016</PRIMARY_ID>
      <SUBMITTER_ID namespace="SUB14282565">CA-CDPH-6000004366_01</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical</TITLE>
    <STUDY_REF accession="SRP333867">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP333867</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA750736</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Whole genome sequencing of SARS-CoV-2</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS20633878">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS20633878</PRIMARY_ID>
          <SUBMITTER_ID namespace="pda|emily.smith@theiagen.com">CA-CDPH-6000004366-0</SUBMITTER_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CA-CDPH-6000004366_01</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>RT-PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>GridION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX23811017" alias="CA-CDPH-6000005057_01">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX23811017</PRIMARY_ID>
      <SUBMITTER_ID namespace="SUB14282565">CA-CDPH-6000005057_01</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical</TITLE>
    <STUDY_REF accession="SRP333867">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP333867</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA750736</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Whole genome sequencing of SARS-CoV-2</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS20633879">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS20633879</PRIMARY_ID>
          <SUBMITTER_ID namespace="pda|emily.smith@theiagen.com">CA-CDPH-6000005057-0</SUBMITTER_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CA-CDPH-6000005057_01</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>RT-PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>GridION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX23811018" alias="CA-CDPH-6000005818_01">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX23811018</PRIMARY_ID>
      <SUBMITTER_ID namespace="SUB14282565">CA-CDPH-6000005818_01</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical</TITLE>
    <STUDY_REF accession="SRP333867">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP333867</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA750736</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Whole genome sequencing of SARS-CoV-2</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS20633880">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS20633880</PRIMARY_ID>
          <SUBMITTER_ID namespace="pda|emily.smith@theiagen.com">CA-CDPH-6000005818-0</SUBMITTER_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CA-CDPH-6000005818_01</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>RT-PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>GridION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX23811019" alias="CA-CDPH-6000013619_01">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX23811019</PRIMARY_ID>
      <SUBMITTER_ID namespace="SUB14282565">CA-CDPH-6000013619_01</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical</TITLE>
    <STUDY_REF accession="SRP333867">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP333867</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA750736</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Whole genome sequencing of SARS-CoV-2</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS20633881">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS20633881</PRIMARY_ID>
          <SUBMITTER_ID namespace="pda|emily.smith@theiagen.com">CA-CDPH-6000013619-0</SUBMITTER_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CA-CDPH-6000013619_01</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>RT-PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>GridION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX23811020" alias="CA-CDPH-6000015831_01">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX23811020</PRIMARY_ID>
      <SUBMITTER_ID namespace="SUB14282565">CA-CDPH-6000015831_01</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>Genomic sequencing of SARS-CoV-2: Clinical</TITLE>
    <STUDY_REF accession="SRP333867">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP333867</PRIMARY_ID>
        <EXTERNAL_ID namespace="BioProject">PRJNA750736</EXTERNAL_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Whole genome sequencing of SARS-CoV-2</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS20633882">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS20633882</PRIMARY_ID>
          <SUBMITTER_ID namespace="pda|emily.smith@theiagen.com">CA-CDPH-6000015831-0</SUBMITTER_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>CA-CDPH-6000015831_01</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>VIRAL RNA</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>RT-PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <OXFORD_NANOPORE>
        <INSTRUMENT_MODEL>GridION</INSTRUMENT_MODEL>
      </OXFORD_NANOPORE>
    </PLATFORM>
  </EXPERIMENT>
</EXPERIMENT_SET>
